|Systematic (IUPAC) name|
|Inhalation and eye drops|
|R01 R03, S01|
|(what is this?)|
Nedocromil sodium is a medication considered as mast cell stabilizer which act to prevent wheezing, shortness of breath, and other breathing problems caused by asthma. It is administered by an inhaler under the brand name Tilade (although its effects in this form are far less than those in albuterol or other well-known inhaler medications) and as an eye drop under the brand name Alocril. Liquid preparations are available in the UK under the name Rapitil for use for allergic eye reactions.
Nedocromil is classified as a cromone. Nedocromil acts as a mast cell stabilizer, inhibits the degranulation of mast cells, prevents release of histamine and tryptase, so preventing the synthesis of prostaglandins and leukotrienes. US Production of inhaled nedocromil ceased in April 2008.
Media related to Nedocromil at Wikimedia Commons
- "ALOCRIL Product Information". ALLERGAN. Retrieved 17 May 2013.
- "ALOCRIL (nedocromil sodium) solution/ drops". NIH. Retrieved 17 May 2013.
- "Nedocromil eye drops". 2007-02-02. Retrieved 2009-08-04.
- "Questions and Answers:Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil". Retrieved 18 September 2014.
|This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.|